Sam won an MRC Training Fellowship to perform a PhD and then a post-doctoral period working in the CRUK Lincoln’s Inn Fields Institute with Fiona Watt working on integrin adhesion molecules and cancer cell survival. He then moved as an MRC Clinician Scientist to UCL leading a group interested in the role of stem cells in lung cancer pathogenesis and treatment of lung disease using cell therapies. He was awarded a Wellcome Trust Senior Clinical Fellowship in October 2010 to work on novel cell therapies for lung cancers resulting in a DPFS first-in-man award and recently won his Wellcome Senior Fellowship renewal to study the genetic and cellular changes lung cancer pathogenesis. The ambition is that from this knowledge he can develop therapies detecting and targeting early lung cancers and thereby dramatically improve outcomes.
He works as a respiratory consultant at UCLH with a particular interest in Lung Cancer, mesothelioma, interventional and diagnostic bronchoscopy and early lung cancer detection. He is Head of Respiratory Research Department at UCL, director of the Lung Cancer Board for London Cancer, lead for Pulmonary at the International Society of Cellular Therapies and Vice-Chair of the National ‘Clinical Expert Group’ on Lung Cancer.
Early Detection of Lung Cancer
Unlike most cancers there has been little progress in cure rates for lung cancer over the past two decades. It has become clear that the key drive for research must be to detect lung cancers early, or, even better, detect those at risk of developing the disease.
EVEN MORE SEMINARS
Dr Shreerang Bhide Royal Marsden Hospital
Circulating HPV DNA in Locally advanced head and neck cancer.
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Camilo Colaco ImmunoBiology
The immunobiology of immunotherapy
Merina Ahmed Royal Marsden NHS foundation Trust
Stereotactic Radiotherapy for lung tumours and oligometastatic disease
Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath University Hospital Southampton NHS Foundation Trust.
Targeted therapies: aiming at the tumour micro-environment